Cargando…

A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use

BACKGROUND: Substance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiercigroch, David, Sheikh, Hasan, Hulme, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958640/
https://www.ncbi.nlm.nih.gov/pubmed/31931831
http://dx.doi.org/10.1186/s13011-019-0250-1
_version_ 1783487457062289408
author Wiercigroch, David
Sheikh, Hasan
Hulme, Jennifer
author_facet Wiercigroch, David
Sheikh, Hasan
Hulme, Jennifer
author_sort Wiercigroch, David
collection PubMed
description BACKGROUND: Substance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier access to medical treatment for substance use disorder (SUD). Patients attend on a walk-in basis without requiring an appointment or referral. We describe the RAAM clinic model, including referral patterns, patient demographics and substance use patterns. Secondary outcomes include retention in treatment and changes in both self-reported and objective substance use. METHODS: The Electronic Medical Record at the clinic was reviewed for the first 26 weeks of the clinic’s operation. We identified SUD diagnoses, referral source, medications prescribed, retention in care and self-reported substance use. RESULTS: The clinic saw 64 unique patients: 66% had alcohol use disorder (AUD), 39% had opiate use disorder (OUD) and 20% had stimulant use disorder. Fifty-five percent of patients were referred from primary care providers, 30% from the emergency department and 11% from withdrawal management services. Forty-two percent remained on-going patients, 23% were discharged to other care and 34% were lost to follow-up. Gabapentin (39%), naltrexone (39%), and acamprosate (15%) were most frequently prescribed for AUD. Patients with AUD reported a significant decrease in alcohol consumption at their most recent visit. Most patients (65%) with OUD were prescribed buprenorphine, and most patients with OUD (65%) had a negative urine screen at their most recent visit. CONCLUSION: The RAAM model provides low-barrier, accessible outpatient care for patients with substance use disorder and facilitates the prescription of evidence-based pharmacotherapy for AUD and OUD. Patients referred by their primary care physician and the emergency department demonstrated a reduction in median alcohol consumption and high rates of opioid abstinence.
format Online
Article
Text
id pubmed-6958640
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69586402020-01-17 A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use Wiercigroch, David Sheikh, Hasan Hulme, Jennifer Subst Abuse Treat Prev Policy Research BACKGROUND: Substance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier access to medical treatment for substance use disorder (SUD). Patients attend on a walk-in basis without requiring an appointment or referral. We describe the RAAM clinic model, including referral patterns, patient demographics and substance use patterns. Secondary outcomes include retention in treatment and changes in both self-reported and objective substance use. METHODS: The Electronic Medical Record at the clinic was reviewed for the first 26 weeks of the clinic’s operation. We identified SUD diagnoses, referral source, medications prescribed, retention in care and self-reported substance use. RESULTS: The clinic saw 64 unique patients: 66% had alcohol use disorder (AUD), 39% had opiate use disorder (OUD) and 20% had stimulant use disorder. Fifty-five percent of patients were referred from primary care providers, 30% from the emergency department and 11% from withdrawal management services. Forty-two percent remained on-going patients, 23% were discharged to other care and 34% were lost to follow-up. Gabapentin (39%), naltrexone (39%), and acamprosate (15%) were most frequently prescribed for AUD. Patients with AUD reported a significant decrease in alcohol consumption at their most recent visit. Most patients (65%) with OUD were prescribed buprenorphine, and most patients with OUD (65%) had a negative urine screen at their most recent visit. CONCLUSION: The RAAM model provides low-barrier, accessible outpatient care for patients with substance use disorder and facilitates the prescription of evidence-based pharmacotherapy for AUD and OUD. Patients referred by their primary care physician and the emergency department demonstrated a reduction in median alcohol consumption and high rates of opioid abstinence. BioMed Central 2020-01-13 /pmc/articles/PMC6958640/ /pubmed/31931831 http://dx.doi.org/10.1186/s13011-019-0250-1 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wiercigroch, David
Sheikh, Hasan
Hulme, Jennifer
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title_full A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title_fullStr A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title_full_unstemmed A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title_short A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
title_sort rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958640/
https://www.ncbi.nlm.nih.gov/pubmed/31931831
http://dx.doi.org/10.1186/s13011-019-0250-1
work_keys_str_mv AT wiercigrochdavid arapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse
AT sheikhhasan arapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse
AT hulmejennifer arapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse
AT wiercigrochdavid rapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse
AT sheikhhasan rapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse
AT hulmejennifer rapidaccesstoaddictionmedicineclinicfacilitatestreatmentofsubstanceusedisorderandreducessubstanceuse